ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,307.01
-0.27%
US Tech 100
18,307.60
0.41%
다우존스 지수
39,671.04
-0.51%
Bitcoin
69,399.58
0.43%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Galectin Therapeutics Inc (GALT)

  7. Galectin Therapeutics Inc (GALT) 뉴스

GALT

Galectin Therapeutics (GALT)

Galectin Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:GALT
일자시간출처헤드라인심볼기업
2024/05/1520:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GALTGalectin Therapeutics Inc
2024/05/1520:50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GALTGalectin Therapeutics Inc
2024/03/0502:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2024/02/0806:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2024/02/0806:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2024/02/0806:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2024/02/0806:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2024/02/0806:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2024/02/0806:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2024/02/0806:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2024/02/0806:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2024/02/0806:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2024/02/0806:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2024/02/0806:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2024/01/1701:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2024/01/0222:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2023/12/1822:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2023/12/1206:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GALTGalectin Therapeutics Inc
2023/12/0801:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GALTGalectin Therapeutics Inc
2023/12/0206:50Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2023/12/0206:38Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:GALTGalectin Therapeutics Inc
2023/12/0122:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2023/11/1607:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
2023/11/1323:21Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:GALTGalectin Therapeutics Inc
2023/11/1322:45GlobeNewswire Inc.UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business UpdateNASDAQ:GALTGalectin Therapeutics Inc
2023/11/1322:00GlobeNewswire Inc.Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business UpdateNASDAQ:GALTGalectin Therapeutics Inc
2023/11/1321:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GALTGalectin Therapeutics Inc
2023/11/1321:50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GALTGalectin Therapeutics Inc
2023/11/0321:00GlobeNewswire Inc.Galectin Therapeutics to Share Five Scientific Presentations at The Liver Meeting™ 2023, Hosted by the AASLDNASDAQ:GALTGalectin Therapeutics Inc
2023/11/0105:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
 검색 관련기사 보기:NASDAQ:GALT

최근 히스토리

USOTC
DTEGY
Deutsche Telekom (QX)
COIN
BTCUSD
Bitcoin
AMEX
XLE
Energy Select Sector SPDR
CCOM
US500
US 500
NASDAQ
GOOGL
Alphabet
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
ADDYY
Adidas (QX)
NYSE
CVX
Chevron
FX
USDEUR
US Dollar vs Euro
NASDAQ
NVDA
NVIDIA
NYSE
JPM
JP Morgan Chase
CCOM
SILVER
SILVER
NYSE
NKE
Nike
COIN
SOLUSD
Solana
NYSE
BAC
Bank of America
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유